RT Journal Article
SR Electronic
T1 782-D Systemic delivery of novel, allosteric STING agonist CRD3874-SI leads to robust anti-cancer activity by generating pro-inflammatory Type I IFN signals while blocking proton channel mediated toxicity
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1814
OP A1814
DO 10.1136/jitc-2023-SITC2023.0782-D
VO 11
IS Suppl 2
A1 Banerjee, Monali
A1 Middya, Sandip
A1 Shrivastava, Ritesh
A1 Middya, Anindita
A1 Mane, Nagaswamy
A1 Rawat, Nidhi
A1 Soram, Thanilsana
A1 Chakraborty, Debjani
A1 Ghosh, Rajib
A1 Mansuri, Rubeena Rais
A1 Yadav, Dharmendra
A1 Gautam, Anuj
A1 Singh, Anuj
A1 Puniya, Kavita
A1 Pryde, David
A1 Basu, Sourav
A1 Sonego, Fabiane
A1 Martin, Gaelle
A1 Martin-Jeantet, Perrine
A1 Pappalardo, Angela
A1 Thiam, Kader
A1 Kelly, Ciara
A1 Surya, Arjun
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_2/A1814.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.